CABERGOLINE

Generic: CABERGOLINE

Ingenus PharmaceuticalsManufacturer
ORALRoute
CABERGOLINEActive Substance
2018-08-01Original Approval

CABERGOLINE is FDA application ANDA204735, sponsored by INGENUS PHARMS LLC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
407 reports
2
OFF LABEL USE
391 reports
3
HEADACHE
344 reports
4
NAUSEA
291 reports
5
FATIGUE
290 reports
6
DIZZINESS
240 reports
7
MALAISE
215 reports
8
PAIN
200 reports
9
DIARRHOEA
191 reports
10
RASH
184 reports